Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Buy |
19,945
+1,328
| +7% | +$70.2K | 0.02% | 353 |
|
|
2026
Q1 | $1.03M | Buy |
18,617
+640
| +4% | +$34.7K | 0.02% | 322 |
|
|
2025
Q4 | $882K | Sell |
17,977
-959
| -5% | -$44.7K | 0.02% | 342 |
|
|
2025
Q3 | $817K | Sell |
18,936
-2,385
| -11% | -$93.2K | 0.02% | 368 |
|
|
2025
Q2 | $819K | Buy |
21,321
+2,252
| +12% | +$86.1K | 0.02% | 356 |
|
|
2025
Q1 | $739K | Buy |
19,069
+4,018
| +27% | +$147K | 0.02% | 360 |
|
|
2024
Q4 | $509K | Sell |
15,051
-3,567
| -19% | -$128K | 0.01% | 460 |
|
|
2024
Q3 | $761K | Buy |
18,618
+245
| +1% | +$10K | 0.02% | 361 |
|
|
2024
Q2 | $707K | Sell |
18,373
-152
| -0.8% | -$6.39K | 0.02% | 363 |
|
|
2024
Q1 | $794K | Buy |
18,525
+1,240
| +7% | +$51.1K | 0.02% | 343 |
|
|
2023
Q4 | $641K | Buy |
17,285
+450
| +3% | +$16.2K | 0.02% | 404 |
|
|
2023
Q3 | $610K | Buy |
16,835
+542
| +3% | +$19.2K | 0.02% | 367 |
|
|
2023
Q2 | $581K | Buy |
16,293
+661
| +4% | +$23.7K | 0.02% | 362 |
|
|
2023
Q1 | $556K | Buy |
15,632
+2,930
| +23% | +$103K | 0.02% | 373 |
|
|
2022
Q4 | $446K | Buy |
12,702
+1,423
| +13% | +$47.4K | 0.02% | 424 |
|
|
2022
Q3 | $332K | Sell |
11,279
-3,927
| -26% | -$149K | 0.01% | 442 |
|
|
2022
Q2 | $827K | Sell |
15,206
-224
| -1% | -$12.4K | 0.03% | 267 |
|
|
2022
Q1 | $840K | Sell |
15,430
-634
| -4% | -$34.4K | 0.03% | 301 |
|
|
2021
Q4 | $886K | Sell |
16,064
-2,121
| -12% | -$110K | 0.03% | 284 |
|
|
2021
Q3 | $869K | Buy |
18,185
+3,259
| +22% | +$164K | 0.03% | 287 |
|
|
2021
Q2 | $743K | Buy |
14,926
+1,678
| +13% | +$80.6K | 0.03% | 322 |
|
|
2021
Q1 | $591K | Buy |
13,248
+1,586
| +14% | +$72K | 0.02% | 361 |
|
|
2020
Q4 | $536K | Buy |
11,662
+1,511
| +15% | +$69.4K | 0.02% | 312 |
|
|
2020
Q3 | $478K | Buy |
10,151
+893
| +10% | +$44.7K | 0.02% | 292 |
|
|
2020
Q2 | $472K | Buy |
9,258
+887
| +11% | +$45.5K | 0.03% | 278 |
|
|
2020
Q1 | $396K | Buy |
8,371
+1,421
| +20% | +$75.8K | 0.03% | 261 |
|
|
2019
Q4 | $408K | Buy |
6,950
+290
| +4% | +$16.1K | 0.02% | 348 |
|
|
2019
Q3 | $355K | Buy |
6,660
+326
| +5% | +$16.8K | 0.02% | 363 |
|
|
2019
Q2 | $317K | Buy |
6,334
+1,321
| +26% | +$66.3K | 0.02% | 401 |
|
|
2019
Q1 | $262K | Buy |
5,013
+193
| +4% | +$9.64K | 0.02% | 445 |
|
|
2018
Q4 | $230K | Buy |
4,820
+186
| +4% | +$9.16K | 0.02% | 456 |
|
|
2018
Q3 | $233K | Buy |
4,634
+120
| +3% | +$6.1K | 0.01% | 500 |
|
|
2018
Q2 | $227K | Buy |
+4,514
| New | +$227K | 0.01% | 485 |
|
Other funds holding GSK
JEST
Bailard's GSK Position: Q2 2026 in Review
Bailard increased its GSK (GSK) stake by 7.1% in Q2 2026, buying an estimated $70.2K and bringing the position to 19,945 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #353.
Bailard first reported a position in GSK in Q2 2018 and has held it in 33 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Bailard held 19,945 shares of GSK worth $1.05M as of Q2 2026.
- Bailard bought 1,328 GSK shares in Q2 2026, an estimated $70.2K.
- GSK made up 0.02% of Bailard's portfolio in Q2 2026, its #353 holding.
- Bailard first reported a position in GSK in Q2 2018 and has held it in 33 quarters since.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.